Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Eli Lilly on Thursday said it will start late-stage trials on its experimental amylin obesity drug next month after it showed encouraging results in a mid-stage study
CJC-1295 without DAC (also called Mod GRF 1-29) is a 29-amino-acid synthetic analog of growth hormone-releasing hormone, engineered with four amino acid substitutions to resist enzymatic degradation
Gut 50 (3), 341348
Payments: Patients will pay a $50 co-payment monthly, with government covering the remaining costs
US$ 27.19
US$ 27.21
.png)
US$ 22.91
US$ 26.49
